U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
194221194221Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder CancerActive, not recruitingNo Results AvailableBladder CancerDrug: cisplatin|Drug: gemcitabine hydrochloride|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00006118
194222194222Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingNo Results AvailablePancreatic CancerDrug: gemcitabine hydrochloride|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00006117
194223194223Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableLung CancerDrug: cisplatin|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00006116
194224194224Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerActive, not recruitingNo Results AvailableColorectal CancerDrug: FOLFIRI regimen|Drug: FOLFOX regimen|Drug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00006115
194225194225Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyActive, not recruitingNo Results AvailableProstate CancerDrug: mitoxantrone hydrochloride|Drug: vinorelbine tartratehttps://ClinicalTrials.gov/show/NCT00006114
194226194226Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV MelanomaTerminatedNo Results AvailableMelanoma (Skin)Biological: MART-1 antigen|Biological: aldesleukin|Biological: gp100 antigen|Biological: recombinant CD40-ligand|Biological: recombinant interferon gamma|Biological: recombinant interleukin-4|Biological: sargramostim|Biological: therapeutic autologous dendritic cells|Biological: therapeutic tumor infiltrating lymphocytes|Biological: tyrosinase peptide|Radiation: Candida albicans skin test reagenthttps://ClinicalTrials.gov/show/NCT00006113
194227194227Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal CancerActive, not recruitingNo Results AvailableCarcinoma of the Appendix|Colorectal Cancer|Primary Peritoneal Cavity CancerDrug: chemotherapy|Drug: fluorouracil|Drug: leucovorin calcium|Drug: mitomycin Chttps://ClinicalTrials.gov/show/NCT00006112
194228194228Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary TractActive, not recruitingNo Results AvailableBladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral CancerDrug: cisplatin|Drug: fluorouracil|Procedure: conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00006111
194229194229Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast CancerCompletedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel|Procedure: conventional surgery|Radiation: Radiation Therapyhttps://ClinicalTrials.gov/show/NCT00006110
194230194230Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: capecitabine|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00006108
194231194231Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerActive, not recruitingNo Results AvailableHead and Neck CancerDrug: docetaxel|Procedure: conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00006107
194232194232ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck CancerWithdrawnNo Results AvailableLip and Oral Cavity Cancer|Head and Neck Cancer|Oropharyngeal CancerDrug: cisplatin|Drug: fluorouracil|Drug: ONYX-015https://ClinicalTrials.gov/show/NCT00006106
194233194233Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder CancerCompletedNo Results AvailableBladder Cancer|Drug/Agent Toxicity by Tissue/OrganDrug: amifostine trihydrate|Drug: cisplatin|Drug: gemcitabine hydrochloride|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00006105
194234194234Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast CancerCompletedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00006104
194235194235Combination Chemotherapy in Treating Patients With Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calciumhttps://ClinicalTrials.gov/show/NCT00006103
194236194236Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaCompletedNo Results AvailableBrain and Central Nervous System Tumors|Lymphoma|Neuroblastoma|Retinoblastoma|Sarcoma|Unspecified Childhood Solid Tumor, Protocol SpecificDrug: becatecarinhttps://ClinicalTrials.gov/show/NCT00006102
194237194237Eflornithine in Treating Patients At High Risk of Developing Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDrug: eflornithinehttps://ClinicalTrials.gov/show/NCT00006101
194238194238Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's LymphomaActive, not recruitingNo Results AvailableLymphomaBiological: aldesleukin|Biological: allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes|Drug: fludarabine phosphate|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00006100
194239194239Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian CancerCompletedNo Results AvailableOvarian CancerOther: immunohistochemistry staining method|Procedure: biopsy|Procedure: immunoscintigraphy|Radiation: indium In 111 monoclonal antibody Hu3S193https://ClinicalTrials.gov/show/NCT00006099
194240194240PS-341 in Treating Patients With Hematologic CancerCompletedNo Results AvailableLeukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic SyndromesDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00006098
194241194241Chemotherapy in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNo Results AvailableLeukemiaDrug: CC-1088https://ClinicalTrials.gov/show/NCT00006097
194242194242Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the VulvaTerminatedNo Results AvailableVulvar CancerDrug: cisplatin|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00006096
194243194243Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous TherapyCompletedNo Results AvailableUnspecified Childhood Solid Tumor, Protocol SpecificDrug: irinotecan hydrochloride|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00006095
194244194244Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumCompletedNo Results AvailableAdenocarcinoma of the Rectum|Stage II Rectal Cancer|Stage III Rectal CancerDrug: oxaliplatin|Drug: fluorouracil|Radiation: external beam radiation therapyhttps://ClinicalTrials.gov/show/NCT00006094
194245194245EMD 121974 in Treating Patients With Progressive or Recurrent GliomaCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: cilengitidehttps://ClinicalTrials.gov/show/NCT00006093
194246194246Arsenic Trioxide for Induction Therapy of Adult Patients With LeukemiaTerminatedNo Results AvailableLeukemiaDrug: Arsenic Trioxidehttps://ClinicalTrials.gov/show/NCT00006092
194247194247Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous TreatmentWithdrawnNo Results AvailableLeukemiaDrug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00006091
194248194248Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic LeukemiaWithdrawnNo Results AvailableLeukemiaDrug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00006090
194249194249Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNo Results AvailableEndometrial Adenocarcinoma|Recurrent Endometrial Carcinoma|Stage III Endometrial Carcinoma|Stage IV Endometrial CarcinomaBiological: trastuzumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00006089
194250194250Vinorelbine in Treating Patients With Metastatic or Advanced Solid TumorsActive, not recruitingNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: vinorelbine tartratehttps://ClinicalTrials.gov/show/NCT00006088

* Görseller ve İçerik tekif hakkına sahip olabilir